Erratum: Simultaneous LC-MS/MS determination of phenylbutyrate, phenylacetate, benzoate and their corresponding metabolites phenylacetylglutamine and hippurate in blood and urine (Journal of Inherited Metabolic Disease (2010) DOI: 10.1007/s10545-010-9172-9);Simultaneous LC-MS/MS determination of phenylbutyrate, phenylacetate benzoate and their corresponding metabolites phenylacetylglutamine and hippurate in blood and urine

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages 703-

  Laryea, Maurice D ^a   Herebian, Diran ^a   Meissner, Thomas ^a   Mayatepek, Ertan ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BENZOIC ACID DERIVATIVE; BIOLOGICAL MARKER; GLUTAMINE; HIPPURIC ACID; HIPPURIC ACID DERIVATIVE; PHENYLACETIC ACID; PHENYLACETIC ACID DERIVATIVE; PHENYLACETYLGLUTAMINE; DRUG DERIVATIVE;

ANALOGS AND DERIVATIVES; BIOTRANSFORMATION; BLOOD; CALIBRATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HYPERAMMONEMIA; LIMIT OF DETECTION; PREDICTIVE VALUE; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; STANDARD; STANDARDS; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY; UREA CYCLE DISORDERS, INBORN; URINE; VALIDATION STUDY; ARTICLE; UREA CYCLE DISORDER;

BENZOATES; BIOLOGICAL MARKERS; BIOTRANSFORMATION; CALIBRATION; CHROMATOGRAPHY, REVERSE-PHASE; GLUTAMINE; HIPPURATES; HUMANS; HYPERAMMONEMIA; LIMIT OF DETECTION; LINEAR MODELS; PHENYLACETATES; PHENYLBUTYRATES; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; UREA CYCLE DISORDERS, INBORN;

EID: 84897926652     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9226-z     Document Type: Erratum

References (23)

1. Batshaw ML (1983) Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis. Prog Clin Biol Res 127:69-83
2. Brusilow SW (1991) Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr Res 29:147-150
3. Brusilow SW, Danney M, Waber LJ, Batshaw M, Burton B, Levitsky L, Roth K, McKeethren C, Ward J (1984) Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310:1630-1634
4. Camacho LH, Olson J, Tong WP, Young CW, Spriggs DR, Malkin MG (2007) Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors. Invest New Drugs 25:131-138
5. Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen TL, Grochow LB, Donehower RC (2001) A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin Cancer Res 7:3047-3055
6. Das AM, Illsinger S, Hartmann H, Oehler K, Bohnhorst B, Kuhn-Velten WN, Lucke T (2009) Prenatal benzoate treatment in urea cycle defects. Arch Dis Child Fetal Neonatal Ed 94:F216-F217
7. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282-2292
8. Garg U, Dasouki M (2006) Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clin Biochem 39:315-332
9. Hommes FA (1999) The assay of phenylacetic acid and 4-phenylbutyric acid in physiological fluids. Clin Chim Acta 284:109-111
10. Kubota K, Ishizaki T (1991) Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans. Eur J Clin Pharmacol 41:363-368
11. Kubota K, Horai Y, Kushida K, Ishizaki T (1988) Determination of benzoic acid and hippuric acid in human plasma and urine by high-performance liquid chromatography. J Chromatogr 425:67-75
12. MacArthur RB, Altincatal A, Tuchman M (2004) Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers. Mol Genet Metab 81(Suppl 1):S67-S73
13. Piscitelli SC, Thibault A, Figg WD, Tompkins A, Headlee D, Lieberman R, Samid D, Myers CE (1995) Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. J Clin Pharmacol 35:368-373
14. Samid D, Shack S, Sherman LT (1992) Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52:1988-1992
15. Shih VE (2007) Alternative-pathway therapy for hyperammonemia. N Engl J Med 356:2321-2322
16. Stein WH, Paladini AC, Hirs CHW, Moore S (1954) Phenylacetylglutamine as a constituent of normal human urine. J Am Chem Soc 76:2848-2849
17. Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, Weinberger MS, Headlee DJ, McCall NA, Samid D (1994a) A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res 54:1690-1694
18. Thibault A, Figg WD, McCall N, Samid D, Myers CE, Cooper MR (1994b) A simultaneous assay of the differentiating agents, phenylacetic acid and phenylbutyric acid, and one of their metabolites, phenylacetyl-glutamine, by reversed-phase, high performance liquid chromatography. J Liq Chrom Rel Technol 17:2895-2900
19. Van Hove JL, Vande KK, Hennermann JB, Mahieu V, Declercq P, Mertens S, De BM, Kishnani PS, Jaeken J (2005) Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis 28:651-663
20. Webster LT, Siddiqui UA, Lucas SV, Strong JM, Mieyal JJ (1976) Identification of separate acyl-CoA:glycine and acyl-CoA:Lglutamine N-Acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J Biol Chem 251:3352-3358
21. Wilcken B (2004) Problems in the management of urea cycle disorders. Mol Genet Metab 81(Suppl 1):S86-S91
22. Yu X, Thompson MM, Shi D, Tuchman M (2001) Quantification of benzoic, phenylacetic, and phenylbutyric acids from filter-paper blood spots by gas chromatography-mass spectrometry with stable isotope dilution. Clin Chem 47:351-354
23. Zimmerman L, Jornvall H, Bergstrom J (1990) Phenylacetylglutamine and hippuric-Acid in uremic and healthy subjects. Nephron 55:265-271